Johnson & Johnson chairman and CEO Alex Gorsky is stepping down to spend more time at home due to family health issues and, effective on 3 January, will hand over the reins to long-time J&J veteran and current vice chairman Joaquin Duato, the company said on 19 August. Duato will become CEO and be named a member of the J&J board of directors, while Gorsky will transition to executive chairman.
The changing of the guard is expected to be seamless, since Duato already plays a major role in setting and executing the company’s global pharmaceutical and consumer business strategies, but it will add J&J’s medical device business – an area